Blog

  • New to The Street Proudly Presents: IMG Academy to Be Featured in Original Special Broadcast on Bloomberg Television

    New to The Street Proudly Presents: IMG Academy to Be Featured in Original Special Broadcast on Bloomberg Television

    NEW YORK CITY, NEW YORK / ACCESS Newswire / May 29, 2025 / New to The Street, the nationally recognized business television series, proudly presents an exclusive original broadcast spotlighting IMG Academy, the world leader in sports education. The feature will air Saturday, May 31 at 6:30 PM ET on Bloomberg Television as sponsored programming.

    This televised special provides a rare inside look at IMG Academy’s elite campus, transformative development model, and the innovative tools preparing the next generation of leaders both on and off the field. The segment will highlight how IMG Academy integrates world-class athletic training, rigorous academics, and personalized development to shape future collegiate athletes and high-character individuals.

    IMG Academy Highlights:

    • Top 3 finalist for the World’s Best School Prize – “Supporting Healthy Lives” (only U.S. finalist in the category)

    • 100% college acceptance rate for the Class of 2024

      • 10 student-athletes accepted to Ivy League institutions

      • 20 student-athletes admitted to top 25 U.S. universities

      • 3 student-athletes accepted to U.S. Military Academies

      • 332 student-athletes committed to NCAA Division I, II, III, and NAIA programs

    • 4.35M+ athlete profile views on NCSA by college coaches in 2024

    • 40,000+ college coaches on the NCSA recruiting platform

    • 31,000+ athlete college commitments in 2024

    • 14 partnerships with national sports governing bodies

    Strategic Brand Alliances

    IMG Academy’s mission is reinforced through strategic partnerships with top global brands that share its commitment to performance, innovation, and excellence. These include: Under Armour, Gatorade, Therabody, Merrill, Uni, Dunlop, and NTT Sonority.

    Cross-Platform Distribution

    The Bloomberg Television premiere will be amplified across New to The Street‘s media ecosystem, including distribution to its 2.5M+ YouTube subscribers, syndication across major social platforms, and iconic billboard exposure throughout Times Square and the NYC Financial District.

    About IMG Academy
    IMG Academy is the world’s leading sports education brand, offering a holistic model that prepares student-athletes to succeed in sport, college, and life. Based in Bradenton, Florida, IMG Academy delivers a comprehensive suite of development programs through its state-of-the-art boarding school and sports camps. Its innovative online platform, IMG Academy+, provides personalized coaching with a focus on personal growth through athletic performance. Through its NCSA recruiting network, IMG Academy also connects student-athletes with more than 40,000 college coaches, offering unparalleled access, tools, and guidance to navigate the collegiate recruitment process. To learn more, visit www.imgacademy.com.

    About New to The Street
    New to The Street is a nationally syndicated business media platform known for long-form interviews with founders, executives, and public company leaders. Broadcasting weekly across Fox Business and Bloomberg Television as sponsored programming, the show reaches over 219 million U.S. households. With a digital footprint that includes 2.5+ million YouTube subscribers, 700K+ social followers, and the most powerful billboard presence in Times Square and NYC’s Financial District, New to The Street is the only financial media brand delivering high-impact exposure across broadcast, digital, social, and out-of-home channels.

    Media Contact:
    Monica Brennan
    Monica@NewToTheStreet.com

    SOURCE: New To The Street

    View the original press release on ACCESS Newswire

  • Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

    Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

    STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update call to June 17, 2025, from June 3, 2025, to allow for the implementation of a reverse stock split that will become effective on June 2, 2025.

    Prepared remarks by members of the Applied DNA management team will be followed by a live question-and-answer session with the Company’s sell-side analysts and institutional investors.

    Webcast and Conference Call Date & Time: Tuesday, June 17 @ 4:30 p.m. Eastern Time

    Dial In:

    A replay of the conference call will be available for 7 days following the conclusion of the call:

    • Replay for domestic callers (toll-free): 877-344-7529, replay access code 3446494

    • Replay for international callers: 412-317-0088, replay access code 3446494

    • Replay for Canadian callers (toll-free): 855-669-9658, replay access code 3446494

    An accompanying slide presentation will be embedded in the webcast (live and replay) that will also be accessible as a stand-alone document via the ‘Company Presentations‘ page of the Applied DNA investor relations website. The webcast replay of the call will be available approximately one hour after the end of the call on the ‘Company Events‘ page.

    About Applied DNA Sciences

    Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (“DNA”). Using the polymerase chain reaction (“PCR”) to enable both the production and detection of DNA, we operate in two business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase (“RNAP”) for use in the production of mRNA therapeutics; and (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services.

    Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.

    For additional information:

    Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com

    Web: https://investors.adnas.com/

    SOURCE: Applied DNA Sciences, Inc.

    View the original press release on ACCESS Newswire

  • Unusual Machines to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3rd at 10:00 a.m. EDT

    Unusual Machines to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3rd at 10:00 a.m. EDT

    ORLANDO, FL / ACCESS Newswire / May 29, 2025 / Unusual Machines, Inc. (NYSE American:UMAC) (“Unusual Machines” or the “Company”), a leading U.S. manufacturer of drone components, today announced that CEO Allan Evans has been invited to present at the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” presented by Maxim Group LLC, on Tuesday, June 3rd – Thursday, June 5th at 10:00 a.m. EDT.

    Unusual Machines will be taking part in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow.” The rapid evolution of technology is paving the way for disruption across all industries, including healthcare, drones, consumer IoT, business solutions, gaming & entertainment, and more. In Maxim’s 2025 Virtual Tech Conference, we will explore how emerging growth companies are expanding their use of Quantum Computing and Artificial Intelligence (AI) to position themselves for the future. Maxim Senior Analysts will facilitate engaging dialogues with CEOs and key management of diverse companies who have their attention on technology and how it will impact and grow their business.

    Unusual Machines presentation is scheduled for Tuesday, June 3rd at 10am EDT.

    This conference will be live on M-Vest. To attend, sign up to become an M-Vest member.

    Click here to learn more and reserve your seat

    About Maxim Group LLC

    Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB) and is a member of FINRA SIPC, and NASDAQ.

    About Unusual Machines

    Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot e-commerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032. For more information, please visit www.unusualmachines.com.

    Investor Contact:
    CS Investor Relations
    investors@unusualmachines.com
    917-633-8980

    SOURCE: Unusual Machines, Inc.

    View the original press release on ACCESS Newswire

  • CIO Association of Canada Revives Prestigious “CIO of the Year Awards” in Partnership with Tech Newsday National Recognition Returns October 2025 with New Categories, Expanded Reach, and Renewed Purpose

    CIO Association of Canada Revives Prestigious “CIO of the Year Awards” in Partnership with Tech Newsday National Recognition Returns October 2025 with New Categories, Expanded Reach, and Renewed Purpose

    TORONTO, ON / ACCESS Newswire / May 29, 2025 / The CIO Association of Canada (CIOCAN) is thrilled to announce the return of the iconic Canadian CIO of the Year Awards, set for October 2025, in strategic partnership with Jim Love and Tech Newsday. This national celebration will honour Canada’s most exceptional technology leaders-visionaries reshaping industries, driving digital transformation, and delivering measurable value to their organizations and communities that they serve.

    Launched initially by Fawn Annan when she was President of IT World Canada (ITWC), the Canadian CIO of the Year Awards have recognized Canada’s top echelon of technology leadership for over a decade. In later years the Awards grew in partnership with CIOCAN, including CIOCAN members serving as the exclusive judges of the awards each year.

    The Awards were a project that Fawn and I both developed and nurtured. Even when times were tough, we found a way to keep them going. Now that IT World is no longer publishing, we’re in the process of continuing its mission under a new name – Tech Newsday. And thanks to our partnership with CIOCAN we have a path to continue the tradition of celebrating the accomplishments of Canada’s technology leadership in these awards.” Jim Love, publisher of Tech Newsday.

    With this relaunch, CIOCAN is ensuring the legacy not only continues but evolves.

    Technology leaders are at the heart of every successful transformation story – whether it’s modernizing public services, scaling entrepreneurial ventures, or defending against evolving cyber threats,” said Shaun Guthrie, President & Chair of CIOCAN. “These awards celebrate the bold, strategic work of CIOs and CISOs across Canada who don’t just keep the lights on – they illuminate the future.”

    Award Categories for 2025:

    • CIO of the Year – Private Sector

    • CIO of the Year – Public Sector

    • CIO of the Year – Not-for-Profit

    • CISO of the Year

    • Fawn Annan Memorial Award (for leadership and advocacy in technology)

    All winners will receive a complimentary one-year CIOCAN membership and be inducted into the newly created CIOCAN Hall of Fame, a lasting tribute to Canada’s most influential technology trailblazers.

    The event will be supported by national media partners Tech Newsday and Digital Journal, offering widespread recognition and thought leadership visibility.

    Sponsorship Opportunities Available

    Organizations looking to support this landmark event and connect with Canada’s top IT leadership talent can contact Ken Rowley at ken.rowley@ciocan.ca for sponsorship inquiries and partnership packages.

    About the CIO Association of Canada (CIOCAN)

    The CIO Association of Canada is the only national professional association that unites IT executives across the country, empowering them to excel as strategic business leaders. Our members are not just technologists – they are catalysts for change, community builders, and champions of innovation. Through shared learning, peer-to-peer networking, and a commitment to professional excellence, CIOCAN helps Canada’s top tech leaders thrive in a rapidly evolving digital world. Learn more at ciocan.ca.

    About Tech Newsday

    Tech Newsday is a new publication to revive the mission that Fawn Annan and Jim Love shared when they headed IT World Canada. It exists to tell the stories of technology in business and society through a Canadian lens. Publications include Tech Newsday, civicspace.ca and two popular podcasts Hashtag Trending and Cybersecurity Today. Learn more at technewsday.ca

    Media Contact:

    Jessica Bellehumeur
    Membership Development Coordinator,
    The CIO Association of Canada
    Jessica.Bellehumeur@ciocan.ca

    SOURCE: CIO Association of Canada

    View the original press release on ACCESS Newswire

  • Vero and First Business Bank Announce Successful Go-Live of Advanced Title Management System

    Vero and First Business Bank Announce Successful Go-Live of Advanced Title Management System

    NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Vero Technologies, a leading provider of innovative financial technology solutions for asset-based lending, has successfully launched its Title Management System (TMS) with First Business Bank, streamlining the bank’s title processing operations. Vero has enabled straight-through processing for the bank’s entire title management workflow-delivering a new standard of efficiency and automation.

    This implementation marks a significant step forward in modernizing title management for financial institutions, eliminating manual processes, reducing processing times, and improving operational transparency.

    A Fully Automated Title Management Solution

    Through Vero’s technology platform, First Business Bank now benefits from a seamlessly integrated, automated title workflow with key capabilities including:

    • Bulk Digitalization & OCR Processing – High-volume title scanning powered by Optical Character Recognition (OCR) enables automated data extraction and verification.

    • Automated Title-to-Asset Pairing – Seamless integration with First Business Bank’s Loan Management System (LMS) ensures immediate reconciliation between physical and digital title records.

    • FedEx API Integration – Automated shipping label generation and real-time tracking for title transfers and releases.

    • Barcode Scanning for Vaulted Title Tracking – A streamlined title storage and retrieval system, enhancing accuracy and security.

    Driving Efficiency & Scalability for First Business Bank

    By leveraging Vero’s end-to-end automation tools, First Business Bank has significantly reduced the time and labor required for title processing, freeing up internal resources to focus on strategic initiatives and customer service.

    “Partnering with Vero to enhance our Title Management System has been a game-changer,” said Jeff Widholm, Managing Director of Floorplan Financing at First Business Bank. “The ability to automate title intake, processing, and distribution has allowed us to scale more efficiently while improving service levels for our clients. This solution enables us to handle greater volume with precision and speed, reinforcing our commitment to delivering best-in-class financial services.”

    Innovating the Future of Title Management

    Vero Technologies remains committed to driving efficiency and innovation across financial services by offering modular, API-driven technology solutions tailored to the needs of modern lenders.

    “Our collaboration with First Business Bank demonstrates the power of automation in title operations,” said Isaac Zafarani, Co-Founder and COO at Vero Technologies. “By eliminating manual bottlenecks and streamlining workflows, we’re helping financial institutions process titles faster, reduce errors, and enhance transparency. This launch is a milestone in our mission to modernize asset-based lending infrastructure.”

    About First Business Bank

    First Business Bank® specializes in Business Banking, including Commercial Banking and Specialty Finance, Private Wealth, and Bank Consulting services, and through its refined focus delivers unmatched expertise, accessibility, and responsiveness. Specialty Finance solutions are delivered through First Business Bank’s wholly owned subsidiary First Business Specialty Finance, LLC®. First Business Bank is a wholly owned subsidiary of First Business Financial Services, Inc®. (Nasdaq: FBIZ). For additional information, visit firstbusiness.bank.

    About Vero Technologies

    Vero Technologies is a leading financial technology platform for asset finance, providing end-to-end solutions for wholesale finance, trade finance, equipment finance, and title management. Vero’s modular platform enables lenders to streamline loan servicing, risk monitoring, and operational workflows-enhancing efficiency while reducing costs.

    To learn more, visit www.vero-technologies.com.

    Contact: Jason Bartz, info@vero-technologies.com, 404-383-7048

    SOURCE: Vero Finance Technologies

    View the original press release on ACCESS Newswire

  • Terra Innovatum Submits Advanced Nuclear Proposal to NYSERDA to Help the State of New York Meet 2040 Zero-Carbon Goal

    Terra Innovatum Submits Advanced Nuclear Proposal to NYSERDA to Help the State of New York Meet 2040 Zero-Carbon Goal

    Terra Innovatum’s SOLO™ Micro-Modular Reactor Offers Safe, Affordable, and Reliable 24/7 Power Without Refueling for 15 Years Using Off-the-Shelf Readily Available Commercial Components and Licensed LEU Fuel

    NEW YORK, NY and AUSTIN, TX / ACCESS Newswire / May 29, 2025 / Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (“GSRT”) (Nasdaq:GSRT), a publicly traded special purpose acquisition company (“SPAC”), today announced the submission of its response to the New York State Energy Research and Development Authority’s (“NYSERDA”) Advanced Nuclear Request for Information (“RFI”). The submission outlines plans for selecting a potential test reactor site for the Company’s first-of-a-kind micro-modular reactor, SOLO™, intent to establish a designated production unit, and further commercial deployment opportunities to support the state’s zero-emissions electricity target by 2040. Unlike conventional reactors, the compact footprint, modular design, and ability to operate for 15 years without refueling make SOLO™ well-suited for integration into local energy systems.

    In Picture: Rendering of 3 SOLOTM units covering an area of approximately 3,600sqft in a public plaza (totaling 3MWe – 12MWt with Co-Generation).

    “We believe SOLO™ represents a pivotal advancement in clean energy infrastructure,” said Alessandro Petruzzi – Co-founder & CEO of Terra Innovatum. “As electricity demand accelerates, driven by AI, data centers, and industrial manufacturing, solutions like SOLO™ will be critical to delivering reliable, zero-carbon power without placing additional strain on the grid. We are excited to showcase the promise of our technology in addressing the urgent energy needs for New York State and look forward to the opportunity to engage with NYSERDA on a potential test reactor site and deployment framework. Importantly, our response to NYSERDA marks the first of many steps toward deploying scalable, plug-and-play energy solutions across the U.S. and beyond. With its low-cost design, 24/7 output, and 15-year fuel cycle, SOLO™ is uniquely positioned to meet the needs of communities, government entities, and businesses seeking energy certainty in an increasingly electrified world.”

    In Picture: Rendering of 500 SOLOTM units covering a total of 500 MWe – 2,000 MWt (Co-Generation) energy deployment.

    Giordano Morichi – Partner, Chief Business Development Officer & Investor Relations at Terra Innovatum continued: “We see SOLO™ as a transformative and strategic opportunity for New York State to become a national leader in deploying advanced nuclear technologies that enhance energy security, grid resilience, and climate justice. Designed for real-world application, SOLO™ leverages a proven supply chain built entirely on licensed components that have been widely used in the nuclear industry for over 60 years. This approach eliminates the timing and cost risks associated with unlicensed fuels or research-phase technologies with no commercial availability. SOLO™’s inherently safe architecture, scalable deployment model, and cost certainty uniquely positions it to power the State’s industrial hubs, manufacturing sites, ports, transit systems, and data centers, while also revitalizing underserved urban and rural communities. It enables local energy independence, supports sustainable construction, and strengthens resilient infrastructure. In doing so, SOLO™ offers the Empire State a carbon-free, economically competitive energy backbone to meet New York clean energy goals at scale.”

    “Safety is our top priority,” affirmed Cesare Frepoli – Co-Founder, COO & Director of Regulatory Affairs at Terra Innovatum. “The compact footprint of SOLO™-approximately 30 ft x 30 ft-combined with its modularity and embedded safeguards, allows for seamless integration in a wide range of environments without the need for expansive emergency planning zones. Its innovative reactor core design is gas cooled by helium, incorporates licensed, off-the-shelf components and utilizes non-proliferant low-enriched uranium (LEU) fuel, which significantly reduces regulatory risk and enhances safety. There is also no water involved in the system, eliminating the risk of hydrogen generation or explosion. Additionally, on top of the various redundancies, the reactor’s inherently low thermal output ensures it operates well below fuel melting thresholds, further reinforcing its passive safety profile,” Dr. Frepoli concluded.

    SOLO™ can be deployed across a wide range of environments-including dense urban centers, critical infrastructure corridors, and remote industrial zones-without compromising public security. Its use of non-proliferant, licensed nuclear fuel and embedded safeguards ensures a secure and compliant solution. SOLO™ can be a powerful asset in supporting New York State’s clean energy leadership while simultaneously reinforcing grid resilience, advancing environmental and energy priorities, and driving long-term, sustainable economic growth.

    Guided by New York’s Climate Leadership and Community Protection Act, which targets a zero-emissions electricity sector by 2040, NYSERDA’s RFI seeks innovative nuclear solutions to support the state’s energy transformation. Terra Innovatum’s proposal outlines potential deployment scenarios for SOLO™, including site considerations, partners, timeline, and use cases. The Company remains open and eager to engage further with NYSERDA to help advance the role of advanced nuclear energy in New York’s grid.

    Recent Highlights

    Terra Innovatum recently announced a proposed business combination with GSR III Acquisition Corp., positioning the Company to accelerate its mission of delivering zero-carbon, cost-efficient, and reliable power. SOLO™ is the first micro-modular reactor designed for operation on widely available Low-Enriched Uranium (LEU) and is built using commercial off-the-shelf components, enabling a simplified regulatory pathway and reduced construction timelines. Earlier this year, Terra Innovatum submitted its regulatory engagement plan to the U.S. Nuclear Regulatory Commission (NRC), a critical step toward its targeted first commercial deployment in 2028.

    ABOUT NEW YORK STATE ENERGY RESEARCH AND DEVELOPMENT AUTHORITY (NYSERDA)

    NYSERDA offers objective information and analysis, innovative programs, technical expertise, and support to help New Yorkers increase energy efficiency, save money, use renewable energy, and reduce reliance on fossil fuels. A public benefit corporation, NYSERDA has been advancing energy solutions and working to protect the environment since 1975.

    ABOUT TERRA INNOVATUM & SOLOTM

    Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.

    It is anticipated that SOLO™ will be available globally within the next three years. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the proven licensing path for SOLO™ enables rapid deployment and minimizes supply chain risks, ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.

    SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can easily scale to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.

    To learn more, visit www.x-solo.com.

    IMPORTANT INFORMATION FOR SHAREHOLDERS

    This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or constitute a solicitation of any vote or approval.

    In connection with the business combination, a Dutch public limited liability company (“Pubco”), GSR III Acquisition Corp. (“GSRT”) and Terra Innovatum s.r.l. (“Terra Innovatum” and, together with GSR III and Pubco, the “Registrant Parties”) have filed with the SEC a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus of Pubco relating to the offer of securities to be issued in connection with the business combination, and a preliminary proxy statement of GSRT to be distributed to holders of GSRT’s ordinary shares in connection with GSRT’s solicitation of proxies for a vote by GSRT’s shareholders with respect to the Business Combination and other matters described in the Registration Statement. The Registrant Parties also plan to file other documents with the SEC regarding the business combination. After the Registration Statement has been declared effective by the SEC, a definitive proxy statement/prospectus will be mailed to the shareholders of GSRT. INVESTORS OF THE REGISTRANT PARTIES ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROXY STATEMENT/PROSPECTUS CONTAINED THEREIN (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND ALL OTHER DOCUMENTS RELATING TO THE BUSINESS COMBINATION THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION.

    Investors will be able to obtain free copies of the proxy statement/prospectus and other documents containing important information about the Registrant Parties once such documents are filed with the SEC, through the website maintained by the SEC at http://www.sec.gov. In addition, the documents filed by GSRT may be obtained free of charge by written request to GSRT at 5900 Balcones Drive, Suite 100, Austin TX 78731.

    PARTICIPANTS IN THE SOLICITATION

    Each of the Registrant Parties, and their respective directors and executive officers, may be considered participants in the solicitation of proxies with respect to the potential transaction described in this communication under the rules of the SEC. Information about the directors and executive officers of GSRT is set forth in GSRT’s filings with the SEC. Information regarding other persons who may, under the rules of the SEC, be deemed participants in the solicitation of the shareholders in connection with the potential transaction and a description of their direct and indirect interests will be set forth in the Registration Statement (and will be included in the proxy statement/prospectus) and other relevant documents when they are filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

    FORWARD LOOKING STATEMENTS

    The statements contained in this press release that are not purely historical are forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

    The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on GSRT and the other Registrant Parties. There can be no assurance that future developments affecting GSRT and the other Registrant Parties will be those that we have anticipated. These forward-looking statements speak only as of the date this press release is delivered and involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements with respect to the Business Combination; (2) the outcome of any legal proceedings that may be instituted against GSRT, any of the Registrant Parties, the combined company or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (3) the inability to complete the Business Combination due to the failure to obtain approval of the shareholders of GSRT or the SEC’s declaration of the effectiveness of the Registration Statement (which will include the proxy statement/prospectus contained therein) to be filed by the Registrant Parties or to satisfy other conditions to closing; (4) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; (5) the ability of Pubco to meet stock exchange listing standards following the consummation of the Business Combination; (6) the risk that the Business Combination disrupts current plans and operations of Terra Innovatum as a result of the announcement and consummation of the Business Combination; (7) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the Business Combination, including the reorganization described in the business combination agreement; (9) changes in applicable laws or regulations; (10) the possibility that the Registrant Parties or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) the amount of redemption requests made by GSRT shareholders and (12) other risk factors described herein as well as the risk factors and uncertainties described in the Form S-4 and GSRT’s other filings with the SEC, as well as any further risks and uncertainties to be contained in the proxy statement/prospectus filed after the date hereof. In addition, there may be additional risks that neither GSRT nor any of the other Registrant Parties presently know, or that GSRT or the other Registrant Parties currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward- looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made.

    None of GSRT, the other Registrant Parties, or any of their respective affiliates, officers, employees or agents, makes any representation or warranty, either express or implied, in relation to the fairness, reasonableness, adequacy, accuracy, completeness or reliability of the information, statements or opinions, whichever their source, contained in this press release or any oral information provided in connection herewith, or any data it generates and accept no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information. GSRT, the other Registrant Parties and their respective affiliates, officers, employees and agents further expressly disclaim any and all liability relating to or resulting from the use of this press release and any errors therein or omissions therefrom. Further, the information contained herein is preliminary, is provided for discussion purposes only, is only a summary of key information, is not complete and is subject to change without notice.

    In addition, the information contained in this press release is provided as of the date hereof and may change, and neither GSRT nor the other Registrant Parties undertakes any obligation to update or revise any forward- looking statements, whether as a result of new information, inaccuracies, future events or otherwise, except as may be required under applicable securities laws.

    CONTACTS

    Giordano Morichi
    Partner, Chief Business Development Officer & Investor Relations
    Terra Innovatum Srl
    E: g.morichi@terrainnovatum.com
    W: www.x-solo.com

    Nicholas Hresko-Staab
    Investor & Media Relations
    Alliance Advisors IR
    E: TerraIR@allianceadvisors.com

    SOURCE: TERRA INNOVATUM SRL

    View the original press release on ACCESS Newswire

  • 1upHealth Launches Prior Authorization Solution and Technology Partnerships to Support CMS Electronic Prior Authorization Mandate for Health Plans

    1upHealth Launches Prior Authorization Solution and Technology Partnerships to Support CMS Electronic Prior Authorization Mandate for Health Plans

    New Product Streamlines Prior Authorization to Improve Patient, Provider, and Payer Outcomes

    BOSTON, MA / ACCESS Newswire / May 29, 2025 / 1upHealth, a leader in health data interoperability, today announced the launch of its 1up Prior Authorization solution. The solution is designed to ensure compliance with the CMS Interoperability and Prior Authorization final rule (CMS-0057) while delivering measurable ROI through reduced provider burden and lower administrative costs for payers. To accelerate adoption of electronic Prior Authorization (ePA), 1upHealth is also building strategic partnerships with Utilization Management (UM) and Prior Authorization (PA) policy vendors. These partnerships aim to simplify integration and speed up deployment for payer customers.

    While PA programs are intended to manage costs, current processes are largely manual and create significant burdens across the healthcare system. For providers, this burden translates to less time spent on patient care; for payers, it drives up administrative costs and hinders member experience. According to the American Medical Association, 29% of physicians reported that PA led to serious adverse events for patients, and nearly 90% said it contributes to physician burnout. Separately, CAQH estimates that transitioning to ePA could save the industry at least $515M annually.

    The 1up Prior Authorization solution digitizes and streamlines the PA process for health plans by managing complex integrations and providing real-time visibility, flexibility, and control at every stage. Built in accordance with Da Vinci FHIR Implementation Guides, the tool enables connectivity with all major EHRs, PA policy vendors, and utilization management systems. By simplifying prior authorization workflows, 1upHealth’s solution not only ensures regulatory compliance but also delivers measurable improvements for patients, providers, and payers.

    “The CMS final rule not only set the stage for healthcare’s long overdue digital transformation, but it provided the kindling needed to solve one of the industry’s biggest pain points: prior authorization,” said Andrew Boyd, CEO of 1upHealth. “With 1upHealth’s latest releases, we’re taking away the complexity of the PA process while going beyond compliance to drive critical outcomes such as: reduced administrative costs and improved efficiency for payers; broader adoption and reduced burden for providers; and, most importantly, improved outcomes and higher satisfaction for patients.”

    1upHealth is also building its ecosystem of PA partners, offering a comprehensive end-to-end ePA solution that integrates into a health plan’s existing technology stack. The 1up Prior Authorization solution connects to all industry EHRs, PA policy vendors, and UM vendors. Today, 1upHealth is integrated with EHR vendors Epic and Meditech; UM transformation provider Cohere Health; and prior authorization systems vendor Itiliti Health. Additional technology partners are actively testing and growing the ecosystem.

    “Healthcare’s longstanding interoperability issues have made it frustratingly difficult to solve even the most basic challenges, such as ensuring patients receive the right care at the right time,” said Mohammad Jouni, Chief Product and Technology Officer of 1upHealth. “1upHealth is changing that by making it dramatically easier to access and integrate health data. This unlocks critical use cases like electronic prior authorization that not only improve clinical outcomes, but also streamline operations and eliminate the inefficiencies the industry has long accepted as inevitable. This is the foundational infrastructure healthcare has always needed but too often overlooked, and I’m proud that 1upHealth is leading the charge.”

    1upHealth will host a webinar on June 4, titled “ePA in Action: Live Demo + Roadmap to CMS-0057 Compliance” to cover the ePA requirements and introduce its new solution. To learn more and register, visit this page.

    About 1upHealth

    Driven by a purpose of better healthcare for all through better data, 1upHealth is the national leader in health data interoperability and one of the fastest-growing health IT companies in the United States. Our modern data platform is built on a standards-based cloud architecture specifically designed for the healthcare industry, making it easy to acquire, manage, share, and compute data. From leading health plans and state Medicaid agencies to innovative digital health organizations and top-performing ACOs, over 90 health organizations rely on 1upHealth to seamlessly exchange data across the healthcare ecosystem to reduce risk, lower costs, and improve patient outcomes.

    Media Contact

    Elizabeth Grich
    Aria Marketing for 1upHealth
    egrich@ariamarketing.com

    SOURCE: 1upHealth

    View the original press release on ACCESS Newswire

  • Elvictor Group Reports Strong Growth in Seafarer Deployment and Client Base, Projects Significant Expansion in 2025

    Elvictor Group Reports Strong Growth in Seafarer Deployment and Client Base, Projects Significant Expansion in 2025

    ATHENS, GR / ACCESS Newswire / May 29, 2025 / Elvictor Group Inc. (OTC PINK:ELVG) (“Elvictor” or the “Company”), a leader in maritime recruitment and crew management, today announced substantial operational growth across key performance areas in Q1 2025, strengthening its market position and future outlook.

    In Q1 2025, Elvictor reported strong financial results, reporting a net profit of $60,230. Revenue increased to $602,368, up from $572,709 in Q1 2024, driven by the Company’s continued focus on operational efficiency and strategic positioning in the maritime crew management sector.

    Operationally, Elvictor deployed 3,187 seafarers in Q1 2025, a 41.23% increase compared to the average of the two preceding quarters. The Company’s client roster also expanded to 49 clients, reflecting a robust 32.43% year-over-year increase.

    This momentum builds on steady growth achieved throughout 2024, during which onboard seafarer numbers rose from 2,257 in Q1 to 2,570 in Q4 – a 13.9% increase. During the same period, Elvictor’s client base grew from 37 to 43, marking a 16.22% increase.

    Looking forward, Elvictor is engaged in active discussions with potential new clients, representing a fleet expansion opportunity of over 100 vessels. Management anticipates onboarding up to 40 additional vessels by year-end 2025. This fleet growth could drive the deployment of an additional 800 seafarers and deliver a material increase in Elvictor’s EBITDA.

    Konstantinos S. Galanakis, CEO of Elvictor Group Inc. commented: “Our sustained growth trajectory underscores our commitment to excellence in maritime management and recruitment. As we continue to expand both our onboard workforce and client portfolio, we are confident in our ability to scale efficiently, enhance operational performance, and create long-term value for our stakeholders.”

    Elvictor’s strong performance highlights the scalability of its digitalized platform, as well as its longstanding, trusted relationships within the global shipping industry. As the Company pursues further growth in 2025 and beyond, it remains committed to delivering operational excellence, financial transparency, and value-driven client partnerships.

    About Elvictor Group, Inc.

    Elvictor Group, Inc. (OTC PINK: ELVG) is transforming the fragmented maritime industry through its fully digitalized crew and ship management platform designed to enhance operational efficiency and reduce costs. With a strategic focus on AI-driven workforce solutions, M&A-driven expansion, and cost-efficient vessel ownership, Elvictor is ushering in a new era of transparency in the shipping industry. For more information, visit: https://www.elvictorgroup.com, and follow us on LinkedIn.

    Investor and Media Contact:

    Investor Relations
    Jonathan.Paterson@harbor-access.com
    Tel +1 475 477 9401

    Cautionary Note Regarding Forward-Looking Statements

    Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets, and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. The Company does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated status of such statements. Therefore, in no case whatsoever will the Company and its affiliates be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.

    SOURCE: Elvictor Group Inc.

    View the original press release on ACCESS Newswire

  • Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints

    Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints

    A unique oral drug candidate that is shown to restore vision and regenerate the retina in an animal model, addressing a major unmet need in ocular therapeutics

    MIAMI, FLORIDA / ACCESS Newswire / May 29, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), an emerging leader in age-reversal science, today announced compelling preclinical results from a study evaluating its novel oral therapeutic, Telomir-1, in a genetically modified zebrafish model of age-related macular degeneration (AMD). Following a 14-day oral dosing regimen, Telomir-1 reversed central vision response and vision acuity, restored retinal degeneration and architecture, and significantly reduced oxidative stress-achieving improvements across several FDA-recognized surrogate endpoints relevant to AMD.

    The study utilized the Sen57wrn-/-ND6-/+ zebrafish model, which combines genetic mutations associated with premature aging (WRN), mitochondrial dysfunction (ND6), and chronic senescence (Sen57). These animals exhibit progressive retinal degeneration, visual impairment, and oxidative stress-closely modeling dry AMD and geographic atrophy in humans.

    Model Transformation: From Degeneration to Recovery

    Before treatment, the aged (18-month-old) zebrafish demonstrated clear signs of neurodegeneration and visual impairment. Mutant animals showed sluggish, uncoordinated swimming behavior and delayed responses to visual stimuli such as light and movement-evidence of significant vision loss.

    Microscopic analysis of their retinas revealed approximately 15% total retinal degeneration, affecting several critical layers:

    • The inner nuclear layer (INL) was thinned. This layer acts as the retina’s central processing zone, where signals from light-sensitive photoreceptors are refined before being passed deeper into the eye.

    • The ganglion cell layer (GCL) was degraded. This layer contains neurons that form the optic nerve, which sends visual information to the brain. Damage here disrupts vision at its source.

    • The inner plexiform layer (IPL) volume was reduced. IPL is a retinal layer located between the inner nuclear layer (INL) and the ganglion cell layer (GCL). It may contribute to disease processes through inner retinal changes, inflammation, or vitreoretinal interactions.

    • The outer plexiform layer (OPL) showed early deterioration. This layer connects photoreceptors to other retinal cells and is essential for detecting changes in light and contrast.

    In addition to retinal damage, the diseased animals exhibited reactive oxygen species (ROS) levels nearly four times higher than healthy controls-indicating intense oxidative stress-and suffered a 15% mortality rate during the two-week study window.

    After receiving Telomir-1, treated animals demonstrated marked recovery:

    • The zebrafish resumed active, coordinated swimming and responded significantly better to light and movement, reflecting restored vision.

    • Retinal architecture was structurally restored, including:

      • Full recovery of INL thickness, restoring core signal processing in the retina.

      • Improved GCL integrity, reactivating the transmission of visual information to the brain.

      • Significant augmentation of IPL size, indicating improved processing of visual signals

      • Improvement of OPL structure, maintaining input from photoreceptors.

    • ROS levels were reduced by up to 50%, and no mortality occurred in any Telomir-1 treatment group.

    Histological cross-sections confirmed Telomir-1’s ability to regenerate not only the inner retinal layers, but also additional retinal structures-supporting improved-laminar retinal restoration and function.

    Collectively, these results demonstrate Telomir-1’s ability to restore visual function, reverse retinal degeneration, reduce oxidative stress, and improve survival-all from a short oral treatment regimen.

    “This breakthrough reinforces our vision at Telomir: to redefine how we treat age-related diseases by going beyond symptom management and targeting the root mechanisms of degeneration,” said Erez Aminov, Chief Executive Officer of Telomir. “To our knowledge, no oral drug has ever demonstrated this level of retinal restoration and vision recovery in any AMD model-this is a meaningful leap forward for patients and the field.”

    “The preclinical success achieved in this AMD model is truly remarkable,” added Dr. Angel, Chief Scientific Advisor of Telomir. “Telomir-1 when studied orally, restored both structure and function in the retina, demonstrating not just neuroprotection, but true regenerative capacity-a property rarely seen in ophthalmic drug development.”

    Cautionary Note Regarding Forward-Looking Statements

    This press release, statements of Telomir’s management or advisors related thereto, and the statements contained in the news story linked in this release contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications, and the safety of Telomir-1.

    Any forward-looking statements in this press release are based on Telomir’s current expectations, estimates and projections only as of the date of this release. These risks and uncertainties include, but are not limited to, the potential use of the data from our studies, our ability to develop and commercialize Telomir-1 for specific indications and safety of Telomir-1. These and other risks concerning Telomir’s programs and operations are described in additional detail in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is on file with the SEC. Telomir explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

    Contact Information

    Helga Moya
    info@telomirpharma.com
    (786) 396-6723

    SOURCE: Telomir Pharmaceuticals, Inc

    View the original press release on ACCESS Newswire

  • GoodData Rolls Out AI Assistant: Embeddable Generative Analytics You Can Trust

    GoodData Rolls Out AI Assistant: Embeddable Generative Analytics You Can Trust

    Next-Gen Conversational Analytics Now Available, Secure, and Fully Embeddable

    SAN FRANCISCO, CA / ACCESS Newswire / May 29, 2025 / GoodData today announced the general availability of GoodData AI Assistant, a conversational analytics solution that transforms how business users engage with data. Built to scale, the AI Assistant enables users to ask questions in plain language and receive precise, governed insights right where decisions are made.

    As a flagship feature of the GoodData AI platform, the AI Assistant redefines how organizations unlock value from analytics. It blends the power of generative AI with semantic context and robust enterprise controls, making data exploration faster, smarter, and secure by design.

    Conversational Analytics at Enterprise Scale

    With the release of GoodData AI Assistant, organizations gain access to a conversational interface that brings AI-driven data exploration to every user, without compromising governance or performance. With the launch of AI Assistant, GoodData introduces a suite of intelligent capabilities tailored for business decision-makers and designed with enterprise demands at the fore:

    • Natural Language Visualization Creation: Users can generate charts or tables simply by describing what they want to see. The assistant interprets the intent, queries the data model, and renders visual insights in seconds.

    • Autocomplete for Analytics Objects: Query creation becomes faster and more intuitive with predictive suggestions for metrics, attributes, and filters.

    • Deep Search: Users can discover dashboards and visualizations using semantic search and context – no need to know exact names or locations.

    • Insight Saving & Permissions: Users can save ad-hoc visualizations directly into the analytics environment, with configurable access controls to maintain oversight and governance.

    • Next-Step Suggestions: The assistant recommends follow-up actions, helping users refine their analysis and reach insights faster.

    • Usage Governance: Enforce cost control and responsible AI usage with configurable usage limits and monitoring tools.

    • White-Labeling: The assistant can be seamlessly embedded and fully rebranded, enabling clients to offer it as part of their own applications without referencing GoodData.

    • Enterprise-Grade Infrastructure: A high-availability architecture ensures consistent performance, reliability, and scalability for mission-critical deployments.

    How It Works: Under the Hood

    GoodData AI Assistant is built on a modern, scalable architecture designed for enterprise use:

    • RAG Architecture: Uses Retrieval-Augmented Generation (RAG) to pull only the most relevant parts of the semantic layer before sending them to the LLM. This improves speed, accuracy, and scalability – even for large models.

    • Efficient on Large Models: By narrowing the input, the assistant can handle very large semantic layers without compromising performance.

    • LLM-Agnostic: Compatible with all major LLM providers. No vendor or vector store lock-in (e.g., OpenAI), giving full flexibility.

    • Validated by AI: Responses are reviewed using an “LLM-as-a-judge” method, where dedicated models assess and validate answers before returning them to the user.

    This approach ensures accurate, fast, and secure insights while maintaining full enterprise control.

    “GoodData AI Assistant is designed to bridge the gap between technical analytics and accessible decision-making,” said Jan Franek, Senior Product Manager at GoodData. “We’re empowering business users to get reliable insights instantly – while maintaining the control and governance enterprises demand.”

    Why It Matters

    The AI Assistant drastically reduces time-to-insight, supports business users without deep technical knowledge, and integrates directly into existing workflows through APIs and SDKs. It’s more than a chatbot – it’s a business companion that understands your data and your business context.

    Key Benefits

    • Smarter Exploration: From detailed explanations to guided next steps, users receive contextually relevant insights with ease.

    • Faster Time to Value: Empower teams with instant answers that align with your data model and business logic.

    • Secure and Compliant: No data leaves your environment. AI outputs are explainable, auditable, and private by default.

    Composable by Design, Ready for Business

    Part of the broader GoodData AI ecosystem, the AI Assistant is built on a composable architecture, making it easy to use out of the box or embed seamlessly into custom applications via SDKs and APIs. Powered by the Intelligent Semantic Layer and the AI-ready Analytics Lake, it ensures every insight is accurate, governed, and aligned with your business logic.

    Looking Ahead

    The launch of the AI Assistant is a key milestone in the broader GoodData AI vision, where every interaction with analytics is intuitive, intelligent, and context-aware. Looking forward, the AI Assistant will become even more proactive, integrated, and adaptive.

    As part of the evolving GoodData AI platform, the Assistant will continue to benefit from deeper orchestration across the semantic layer, tighter integration with enterprise workflows, and support for the latest advancements in generative AI, always with full flexibility, governance, and control.


    About GoodData

    GoodData is the AI-native analytics platform built for speed, scale, and trust, helping companies deliver real-time insights – embedded, branded, and everywhere your users need them.

    Founded in 2007, and with offices in both the U.S. and Europe, GoodData serves over 140,000 of the world’s top companies and 3.2 million users, helping them drive meaningful change and maximize the value of their data.

    For more information, visit GoodData’s website and follow GoodData on LinkedIn, YouTube, and Medium.

    GoodData Contact

    press@gooddata.com

    ©2025, GoodData Corporation. All rights reserved. GoodData and the GoodData logo are registered trademarks of GoodData Corporation in the United States and other jurisdictions. Other names used herein may be trademarks of their respective owners.

    SOURCE: GoodData

    View the original press release on ACCESS Newswire